Table 3 Patient and tumour characteristics and HIF-2α staining
HIF-2 α, number of patients (%) | |||
|---|---|---|---|
Negative | Positive | P -value | |
Gender | P=0.68 | ||
Male | 19 (34) | 37 (66) | |
Female | 13 (38) | 21 (62) | |
T stage | P=0.53 | ||
T1/2 | 6 (33) | 12 (67) | |
T3/4 | 26 (36) | 46 (64) | |
N stage | P=0.10 | ||
N0 | 17 (30) | 40 (70) | |
N1 | 8 (38) | 13 (62) | |
N2 | 7 (58) | 5 (42) | |
Differentiation | P=0.94 | ||
Well | 2 (50) | 2 (50) | |
Moderate | 25 (34) | 48 (66) | |
Poor | 5 (39) | 8 (61) | |
Dukes’ stage | P=0.25 | ||
Dukes’ A | 6 (35) | 11 (65) | |
Dukes’ B | 11 (28) | 29 (72) | |
Dukes C1 | 12 (43) | 16 (57) | |
Dukes’ C2 | 3 (60) | 2 (40) | |
TNM stage | P=0.28 | ||
Stage I | 6 (35) | 11 (65) | |
Stage II | 11 (28) | 29 (72) | |
Stage III | 15 (46) | 18 (54) | |
Vascular invasion | P=0.74 | ||
Absent | 22 (35) | 41 (65) | |
Intramural | 3 (27) | 8 (73) | |
Extramural | 7 (44) | 9 (56) | |
Microvessel density | P=0.86 | ||
<60 vessels | 13 (34) | 25 (66) | |
⩾60 vessels | 18 (36) | 32 (64) | |
